ADLEAP 160MG

Adleap 160mg tablets contain an active ingredient known as enzalutamide. This medication falls under the category of androgen receptor inhibitors. It is prescribed for adult men diagnosed with prostate cancer. The treatment is intended for men with elevated testosterone levels (who respond to hormonal therapy or have prostate cancer that has metastasized). Notify your physician if you have an allergy to enzalutamide or any of its components. Additionally, inform your doctor if you have a history of liver, kidney, or heart issues (such as irregular heartbeat), seizures, or other cancers (aside from prostate cancer).

Keep your doctor informed about all medications you are taking, both prescribed and over-the-counter, as well as your dietary habits while on this medication. This information will assist your doctor in providing appropriate treatment based on your medical history or in making necessary dosage adjustments. The safety and efficacy of Adleap 160mg tablets in pediatric males have not been established, thus it is not advised for use in this population. If you are planning to conceive or suspect you may be pregnant while breastfeeding, consult your physician.